Inspire Medical Systems Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inspire Medical Systems Inc's ROI in the third quarter of 2026?
Inspire Medical Systems inc achieved a return on average invested assets (ROI) of 12.05 % in its third quarter of 2026, this is above INSP's average return on investment of -8.57%.
Inspire Medical Systems Inc invested over the 12 months ending in its third quarter of 2026 $836 million

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 44 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 383 to 431.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	17.89 %	12.3 %	12.94 %	13.15 %	13.54 %
Y / Y Net Income Change TTM	126.04 %	154.22 %	131.23 %	170.7 %	140.88 %
Investment (TTM) in Millions	856	855	822	811	697
Return On Investment (TTM)	12.05 %	16.96 %	17.04 %	19.67 %	6.28 %
INSP's Overall Ranking	# 431	# 383	# 1178	# 1019	# 822
Seq. Investment Change TTM	4.99 %	3.45 %	4.09 %	4.28 %	0.01 %
Seq. Net Income Change TTM	-25.42 %	2.98 %	-9.82 %	226.38 %	-16.12 %
Net Income (TTM) in Millions	101	135	131	145	45

INSP Company Profile >> Back to INSP Roi Comparisons >> See Annual INSP Return On Investment

Return On Investment INSP's Ranking
Within:	No.
Industry	# 10
Sector	# 45
Overall	# 431

Return On Investment Statistics
High	Average	Low
18.88 %	-8.57 %	-30.41 %
(Dec 31 2025)		(Jun 30 2020)

News about Inspire Medical Systems inc Return on Investment ROI

Inspire Medical Systems Pushes Boundaries of Sleep Apnea Treatment Amidst Financial Hurdles

August 2, 2024

In a recent press release, Inspire Medical Systems, Inc. (NYSE: INSP) announced the FDA s approval of its Inspire V therapy system. This marks a significant milestone for the medical technology company, which specializes in developing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). However, this positive news comes amidst financial difficulties, as Inspire Medical Systems recorded a net loss and a decline in return on investment (ROI) in the first quarter of 2024. In this article, we will delve into the facts surrounding these developments and assess their impact on the company s future.
Factual overview:
Inspire Medical Systems has successfully obtained FDA approval for its Inspire V therapy system, encompassing the next generation neurostimulator, a Bluetooth patient remote, and a physician programmer. This innovative solution offers promising prospects for patients with OSA, providing them with minimally invasive treatment options.

Inspire Medical Systems: Overcoming Financial Hurdles with Milestone Reimbursement in France

July 23, 2024

Inspire Medical Systems, Inc. has recently made a significant stride in France with the publication of reimbursement for its innovative therapy aimed at treating obstructive sleep apnea (OSA). This favorable development comes at a crucial time for the company, as it grapples with a recorded net loss of $16 million in the first quarter of 2024, resulting in a negative return on investment (ROI) of -2.81%. Despite these financial setbacks, Inspire remains committed to providing minimally invasive solutions for OSA patients and moving forward in the healthcare sector.
I. Inspire Medical Systems’ Reimbursement Announcement:
Inspire Medical Systems, Inc. proudly shared news of the publication of reimbursement for Inspire therapy in France. This therapy, designed to address obstructive sleep apnea, represents a significant breakthrough for the medical technology company. Operating on the principle of providing minimally invasive solutions, Inspire aims to revolutionize the treatment options available for OSA patients. With countrywide reimbursement in France, Inspire can now reach a wider audience and help alleviate the burdens faced by those suffering from this sleep disorder.

Financial Statements
Inspire Medical Systems Inc's III. Quarter Investments	$ 856 Millions	INSP's Balance sheet
Inspire Medical Systems Inc's III. Quarter Income	$ -24 Millions	Quarterly INSP's Income Statement
INSP's Income by Division		See INSP's Income by Division

INSP Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	781	690	574	496	245
Y / Y Investment Growth	13.25 %	20.21 %	15.66 %	102.53 %	-3.77 %
Net Income in Millions	145	54	-21	-45	-42
Y / Y Net Income Growth	171.77 %	-	-	-	-
Annual Return On Investment	18.61 %	7.76 %	-3.69 %	-9.05 %	-17.16 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 18.61 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INSP's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INSP's Competitors
Subscribers only: Roi for Inspire Medical Systems Inc's Suppliers
Subscribers only: Return On Investment for INSP's Customers

Other Ratios
INSP's Roa	INSP's Inventory Turnover Ratio	INSP's Growth Rates	INSP's Dividend Statistics
	INSP's Profitability Ratios	INSP's Asset Turnover Ratio	INSP's Dividend Growth
INSP's Roe	INSP's Valuation Ratios	INSP's Financial Strength Ratios	INSP's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Eli Lilly And Company	32.00 %
Caredx Inc	30.65 %
Zevra Therapeutics Inc	29.88 %
Acadia Pharmaceuticals Inc	26.89 %
Standard Biotools Inc	23.91 %
Iradimed Corporation	22.98 %
Corcept Therapeutics Inc	22.08 %
Resmed Inc	21.10 %
Alector Inc	20.83 %
Chemed Corporation	20.46 %
Halozyme Therapeutics Inc	19.64 %
Pro dex Inc	19.11 %
Dexcom Inc	18.92 %
Illumina Inc	18.74 %
Denali Therapeutics Inc	17.88 %
West Pharmaceutical Services Inc	17.65 %
Healthcare Services Group Inc	17.18 %
Neurocrine Biosciences Inc	16.94 %
Krystal Biotech Inc	16.91 %
Vertex Pharmaceuticals Inc	16.63 %
Intuitive Surgical Inc	16.30 %
Hca Healthcare Inc	15.54 %
Kiniksa Pharmaceuticals International Plc	15.45 %
Amgen Inc	13.64 %
Carlisle Companies Incorporated	13.64 %
Bristol myers Squibb Company	13.59 %
3m Company	13.24 %
Beone Medicines Ltd	13.17 %
Regeneron Pharmaceuticals Inc	13.00 %
Abbvie Inc	12.87 %

Date modified: 2026-11-03T16:39:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.